A Former Athlete’s Frustration Fuels Innovation (Image Credits: Pixabay)
David Beckham confronted a routine challenge shared by many health-conscious individuals: managing a pile of daily supplements. He took more than a dozen pills each day but frequently forgot them, relying on his wife Victoria to lay them out. This personal hurdle inspired IM8, the all-in-one supplement brand he co-founded, which now generates $10 million in monthly revenue and has reached $120 million in annual recurring revenue within its first year.
A Former Athlete’s Frustration Fuels Innovation
Beckham, the retired soccer star known for his disciplined fitness regimen, sought a simpler solution after years of juggling multiple supplements. He partnered with Prenetics CEO Danny Yeung to launch IM8 in November 2024. The duo addressed Beckham’s dilemma head-on by developing a single powder that consolidates the benefits of 16 separate products.[1][2]
“From the start, Danny and I shared in the frustration of an overly complicated supplement market,” Beckham stated. Yeung, whose background includes building Prenetics into a public company during the Covid era, saw opportunity in the unregulated industry plagued by questionable products. Their collaboration emphasized clinical validation over hype, setting IM8 apart from competitors.
Science and Expertise Drive Product Excellence
IM8’s flagship Daily Ultimate Essentials Pro packs over 90 clinically dosed ingredients across nine organ systems, targeting energy, digestion, immunity, and more. Recent upgrades include 733% more vitamin B12, added saffron extract, and enhanced magnesium and MSM levels. The brand also offers Daily Ultimate Longevity capsules, which address the 12 hallmarks of aging with NMN and spermidine.[3]
A world-class scientific advisory board lent credibility from day one. Members included experts from Mayo Clinic, former NASA chief scientist James L. Green, and Cedars-Sinai researchers. The products underwent a 12-week randomized clinical trial by the San Francisco Research Institute, where 95% of participants reported more energy and 85% noted better digestion. Every batch receives NSF Certified for Sport testing, screening for over 280 banned substances – a rarity in the sector.[1]
Revenue Milestones Mark Rapid Ascent
IM8 hit $9 million in revenue in October 2025, up 32% from the prior month, and reached $10 million by December. The brand delivered 13 million servings to over 420,000 customers in 31 countries within 11 months, achieving $108 million in annualized recurring revenue at that point.[4][5]
Prenetics, IM8’s parent, reported $60.1 million from the brand in fiscal 2025, contributing to a 480% overall revenue surge to $92.4 million. Projections called for $180-200 million in 2026. Key metrics included 80% of new orders as subscriptions and an average order value rising to $145.[1]
- November 2024: Launch with Daily Ultimate Essentials.
- October 2025: Longevity product debut; $6.8 million monthly revenue.
- December 2025: $10 million monthly; $120 million ARR.
- February 2026: Pro version launch with formula enhancements.
- April 2026: NBA star Giannis Antetokounmpo joins as investor.[6]
Strategies That Transcend Celebrity Appeal
While Beckham’s 88 million Instagram followers aided discovery, IM8 prioritized direct-to-consumer sales for control over messaging. The website features trial data, testing reports, and masterclasses with advisory board members. Ambassadors like tennis star Aryna Sabalenka reinforced the athlete-trusted angle without overshadowing science.[1]
Yeung stressed transparency: “First, whatever industry that you’re in, you have to establish trust and credibility.” Priced at around $100 monthly (with subscriptions at $78), the products appealed to those weary of pill fatigue. Nutrition Business Journal analysts credited efficacy and satisfaction for sustained growth, not just fame.
IM8’s model tapped into the longevity category’s 14.3% expansion in 2025, outpacing the industry’s 5.6%.[1]
Key Takeaways
- IM8 simplifies nutrition with all-in-one formulas backed by clinical trials and elite testing.
- Revenue hit $120 million ARR in year one through DTC focus and scientific transparency.
- Beckham’s involvement adds authenticity, but rigorous validation ensures repeat business.
IM8 proves that solving real consumer pain points with superior science can build an empire faster than star power alone. As the brand expands globally and innovates, it sets a new benchmark for supplements. What do you think about this supplement revolution? Tell us in the comments.
